Company: NDRA
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001654954-25-003612
Chunk: 180

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 13
Chunk 180
---
 the Company and Green Court LLC 10-Q10.205/15/1810.16Second Amendment to Lease, dated March 15, 2021, by and between the Company and Green Court LLC 10-K10.1803/25/2110.17Third Amendment to Lease, dated December 1, 2024, by and between the Company and Green Court LLCx   10.18Consulting Agreement, dated October 17, 2023, by and between the Company and Alexander Tokman* 10-K10.2103/28/2410.19Offer Letter, dated June 9, 2021, by and between the Company and Irina Pestrikova* 10-K10.2203/28/2419.1ENDRA Life Sciences Inc. Insider Trading Policyx   21.1Subsidiaries of the Company 10-K21.103/30/2223.1Consent of RBSM LLP, Independent Registered Public Accounting Firm (with respect to Forms S-3)x   23.2Consent of RBSM LLP, Independent Registered Public Accounting Firm (with respect to Forms S-8)x   24.1Power of Attorney (included on signature page)x   31.1Certification Pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934x   31.2Certification Pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934x   32.1Certification Pursuant to 18 U.S.C Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002x   97Incentive-Based Compensation Recovery Policy 10-K9703/28/24101.INSXBRL Instance Documentx   101.SCHXBRL Taxonomy Schemax   101.CALXBRL Taxonomy Extension Calculation Linkbasex   101.DEFXBRL Taxonomy Extension Definition Linkbasex   101.LABXBRL Taxonomy Extension Label Linkbasex   101.PREXBRL Taxonomy Extension Presentation Linkbasex   

________________ 

* Indicates management compensatory plan, contract or arrangement.

Item 16. Form 10-K Summary

None.

 67Table of Contents

SIGNATURES

Pursuant to the